This Project Grant award from the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) provides $1,574,994 to the University of California, Los Angeles (UCLA) to acquire a state-of-the-art high-resolution tandem mass spectrometer. This specialized instrument will support structural characterization of a broad range of large biological and synthetic molecules across over 11 NIH-funded research projects at the university. The mass spectrometer's capabilities for high-accuracy mass measurements, multistage MS-n experiments, and diverse fragmentation methods will enable advanced top-down analysis to elucidate the sequence, structure, and post-translational modifications of large biomolecules. This equipment will be a vital component for research addressing human health issues including neurodegenerative diseases, infectious diseases, cancer, and viral infections. The award has a performance period from May 15, 2025 to May 14, 2026.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | $1.6m | 5/7/25 |